IL-22 secretion by recipient NKp46-ILC3s in the intestine and thymus was found to prevent GvHD by enhancing intestinal stem cell (ISC) function, thymic regeneration and T-cell reconstitution in post allo-HSCT GvHD models [123,124,125]. The gene discussed is NCR1; the disease is graft versus host disease.